NEW YORK, Oct 27: In 2004, Pfizer, the world’s largest drug company, agreed to plead guilty and pay more than $430 million to settle charges it had illegally marketed the epilepsy drug Neurontin for unapproved uses. Now, a study in the Journal of Clinical Psychiatry questions whether the lawsuit ended up fueling spending on other epilepsy drugs instead of curbing so-called off-label prescribing. (agencies)
Trending Now
E-Paper
Follow our WhatsApp channel